The concept of autoimmune pancreatitis and its immunological backgrounds

Expert Review of Clinical Immunology

Volumn 6, Issue 1, 2010, Pages 125-136

  Pezzilli, Raffaele ^a   Morselli Labate, Antonio M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autoimmune disease; IgG4; Immune system disease; Meta analysis; Pancreatic neoplasms; Pancreatitis

Indexed keywords

IMMUNOGLOBULIN G4; STEROID;

ALLERGIC DISEASE; ALLERGY; AUTOIMMUNE PANCREATITIS; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; PATHOGENESIS; REVIEW; SERODIAGNOSIS; SEROLOGY; STEROID THERAPY;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOLOGICAL MARKERS; DRUG MONITORING; HUMANS; IMMUNOGLOBULIN G; PANCREATITIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77649139978     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.68     Document Type: Review

References (110)

1. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas - an autonomous pancreatic disease? Am. J. Dig. Dis. 6(7), 688-698 (1961).
2. Cavallini G, Frulloni L. Autoimmunity and chronic pancreatitis: a concealed relationship. JOP 2(2), 61-68 (2001).
3. DiMagno EP. Autoimmune chronic pancreatitis: a plea for simplification and consistency. Clin. Gastroenterol. Hepatol. 1(6), 421-422 (2003).
4. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig. Dis. Sci. 40(7), 1561-1568 (1995).
5. Ectors N, Maillet B, Aerts R et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 41(2), 263-268 (1997).
6. Klimstra DS, Conlon KC, Adsay NV. Lymphoplasmacytic sclerosing pancreatitis with pseudotumor formation. Pathol. Case Rev. 6(3), 94-99 (2001).
7. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum. Pathol. 22(4), 387-395 (1991).
8. Pearson RK, Longnecker DS, Chari ST et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 27(1), 1-13 (2003).
9. Frulloni L, Gabbrielli A, Pezzilli R et al. Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig. Liver Dis. 41(4), 311-317 (2009).
10. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N. Engl. J. Med. 355(25), 2670-2676 (2006).
11. Pezzilli R. Acute recurrent pancreatitis: an autoimmune disease? World J. Gastroenterol. 14(7), 999-1006 (2008).
12. Wayne M, Delman KA, Kurt T, Grossi R, Sabatini M, Cooperman A. Autoimmune pancreatitis: unveiling a hidden entity. Arch. Surg. 140(11), 1104-1107 (2005).
13. Wakabayashi T, Kawaura Y, Satomura Y et al. Clinical study of chronic pancreatitis with focal irregular narrowing of the main pancreatic duct and mass formation: comparison with chronic pancreatitis showing diffuse irregular narrowing of the main pancreatic duct. Pancreas 25(3), 283-289 (2002).
14. Tanvetyanon T, Stiff PJ. Recurrent steroid-responsive pancreatitis associated with myelodysplastic syndrome and transformations. Leuk. Lymphoma 46(1), 151-154 (2005).
15. Ohara H, Nakazawa T, Ando T, Joh T. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J. Gastroenterol. 42(Suppl. XVIII), 15-21 (2007).
16. Morana G, Tapparelli M, Faccioli N, D'Onofrio M, Pozzi Mucelli R. Autoimmune pancreatitis: instrumental diagnosis. JOP 6(Suppl. 1), 102-107 (2005).
17. Shanbhogue AK, Fasih N, Surabhi VR et al. A clinical and radiologic review of uncommon types and causes of pancreatitis. Radiographics 29(4), 1003-1026 (2009).
18. Numata K, Ozawa Y, Kobayashi N et al. Contrast-enhanced sonography of autoimmune pancreatitis: comparison with pathologic findings. J. Ultrasound Med. 23(2), 199-206 (2004).
19. Kamisawa T, Imai M, Yui Chen P et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 37(3), e62-e67 (2008).
20. Sahani DV, Kalva SP, Farrell J et al. Autoimmune pancreatitis: imaging features. Radiology 233(2), 345-352 (2004).
21. Okazaki K, Kawa S, Kamisawa T et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J. Gastroenterol. 41(7), 626-631 (2006).
22. Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J. Gastroenterol. 12(16), 2487-2496 (2006).
23. Chari ST, Smyrk TC, Levy MJ et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin. Gastroenterol. Hepatol. 4(8), 1010-1016 (2006).
24. Aparisi L, Farre A, Gomez-Cambronero L et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 54(5), 703-709 (2005).
25. Nahon Uzan K, Levy P, O'Toole D et al. Is idiopathic chronic pancreatitis an autoimmune disease? Clin. Gastroenterol. Hepatol. 3(9), 903-909 (2005).
26. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am. J. Gastroenterol. 99(8), 1605-1616 (2004).
27. Kawa S, Ota M, Yoshizawa K et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 122(5), 1264-1269 (2002).
28. Park DH, Kim MH, Oh HB et al. Substitution of aspartic acid at position 57 of the DQb1 affects relapse of autoimmune pancreatitis. Gastroenterology 134(2), 440-446 (2008).
29. Asaoka Y, Tada M, Isayama H et al. No significant relation between aggravation of autoimmune pancreatitis and substitution of aspartic acid at position 57 of DQb1. J. Gastroenterol. 44(7), 799-800 (2009).
30. Chang MC, Chang YT, Tien YW et al. T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin. Chem. 53(9), 1700-1705 (2007).
31. Mizuno N, Bhatia V, Hosoda W et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUSFNA. J. Gastroenterol. 44(7), 742-750 (2009).
32. Hirano K, Fukushima N, Tada M et al. Diagnostic utility of biopsy specimens for autoimmune pancreatitis. J. Gastroenterol. 44(7), 765-773 (2009).
33. Detlefsen S, Mohr Drewes A, Vyberg M, Klöppel G. Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch. 454(5), 531-539 (2009).
34. Moon SH, Kim MH, Park DH et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 57(12), 1704-1712 (2008).
35. Pezzilli R, Morselli-Labate AM. Steroid responsiveness and treatment regimen of steroids in acute autoimmune pancreatitis. Minerva Gastroenterol. Dietol. 54(4), 407-414 (2008).
36. Kamisawa T, Okamoto A, Wakabayashi T, Watanabe H, Sawabu N. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand. J. Gastroenterol. 43(5), 609-613 (2008).
37. Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 56(12), 1650-1652 (2007).
38. Raina A, Yadav D, Krasinskas AM et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am. J. Gastroenterol. 104(9), 2295-2306 (2009).
39. Devey ME, Wilson DV, Wheeler AW. The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization. Clin. Allergy 6(3), 227-236 (1976).
40. van der Giessen M, Homan WL, van Kernebeek G, Aalberse RC, Dieges PH. Subclass typing of IgG antibodies formed by grasspollen-allergic patients during immunotherapy. Int. Arch. Allergy Appl. Immunol. 50(5), 625-640 (1976).
41. van der Zee JS, van Swieten P, Aalberse RC. Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J. Immunol. 137(11), 3566-3571 (1986).
42. King DJ, Adair JR, Angal S et al. Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment. Biochem. J. 281(pt 2), 317-323 (1992).
43. Angal S, King DJ, Bodmer MW et al. A single amino acid substitution abolishes the heterogeneity of chimeric mouse/ human (IgG4) antibody. Mol. Immunol. 30(1), 105-108 (1993).
44. Zack DJ, Stempniak M, Wong AL, Weisbart RH. Localization of an Fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis. J. Immunol. 155(10), 5057-5063 (1995).
45. Rispens T, Ooievaar-De Heer P, Vermeulen E, Schuurman J, van der Neut Kolfschoten M, Aalberse RC. Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions. J. Immunol. 182(7), 4275-4281 (2009).
46. Punnonen J, De Waal M, van Vlasselaer P, Gauchat JF, De Vries JE. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol. 151(3), 1280-1289 (1993).
47. Miyoshi H, Uchida K, Taniguchi T et al. Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 36(2), 133-140 (2008).
48. Calkhoven PG, Aalbers M, Koshte VL et al. Relation between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalant allergens. I. Establishment of a scoring system for the overall food responsiveness and its application to 213 unselected children. Clin. Exp. Allergy 21(1), 91-98 (1991).
49. Punnonen J, Aversa G, Cocks BG et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl Acad. Sci. USA 90(8), 3730-3734 (1993).
50. Jabara HH, Loh R, Ramesh N, Vercelli D, Geha RS. Sequential switching from m to e via g 4 in human B cells stimulated with IL-4 and hydrocortisone. J. Immunol. 151(9), 4528-4533 (1993).
51. Vercelli D, De Monte L, Monticelli S, Di Bartolo C, Agresti A. To E or not to Eβ Can an IL-4-induced B cell choose between IgE and IgG4? Int. Arch. Allergy Immunol. 116(1), 1-4 (1998).
52. Agresti A, Vercelli D. Analysis of g4 germline transcription in human B cells. Int. Arch. Allergy Immunol. 118(2-4), 279-281 (1999).
53. Meiler F, Klunker S, Zimmermann M, Akdis CA, Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and Toll-like receptors. Allergy 63(11), 1455-1463 (2008).
54. Satoguina JS, Weyand E, Larbi J, Hoerauf A. T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J. Immunol. 174(8), 4718-4726 (2005).
55. Wood N, Bourque K, Donaldson DD et al. IL-21 effects on human IgE production in response to IL-4 or IL-13. Cell. Immunol. 231(1-2), 133-145 (2004).
56. Avery DT, Bryant VL, Ma CS, de Waal MR, Tangye SG. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181(3), 1767-1779 (2008).
57. Ettinger R, Kuchen S, Lipsky PE. The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 223(1), 60-86 (2008).
58. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 357(9258), 752-756 (2001). (Pubitemid 32217683)
59. Krop EJ, Stapel SO, de Vrieze H, van der Zee JS. Immunoglobulin E and G4 antibody responses in occupational airway exposure to bovine and porcine plasma proteins. Int. Arch. Allergy Immunol. 139(3), 237-244 (2006).
60. Matsui EC, Diette GB, Krop EJ et al. Mouse allergen-specific immunoglobulin G and immunoglobulin G4 and allergic symptoms in immunoglobulin E-sensitized laboratory animal workers. Clin. Exp. Allergy 35(10), 1347-1353 (2005).
61. Krop EJ, Matsui EC, Sharrow SD et al. Recombinant major urinary proteins of the mouse in specific IgE and IgG testing. Int. Arch. Allergy Immunol. 144(4), 296-304 (2007).
62. Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr. Opin. Immunol. 18(6), 738-744 (2006).
63. Akdis CA, Blaser K. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect. 3(11), 891-898 (2001).
64. Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J. Allergy Clin. Immunol. 116(5), 961-968 (2005).
65. Chapman MD, Platts-Mills TAE. Measurement of IgG, IgA and IgE antibodies to Dermatophagoides pteronyssinus by antigen-binding assay, using a partially purified fraction of mite extract (F4P1). Clin. Exp. Immunol. 34(1), 126-136 (1978).
66. Thomas WR, Hales BJ. T and B cell responses to HDM allergens and antigens. Immunol. Res. 37(3), 187-199 (2007).
67. Aalberse RC. Structural features of allergenic molecules. Chem. Immunol. Allergy 91(1), 134-146 (2006).
68. Aalberse RC, van der Gaag R, van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 130(2), 722-726 (1983).
69. Hirano K, Kawabe T, Yamamoto N et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin. Chim. Acta 367(1-2), 181-184 (2006).
70. Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity autoimmune pancreatitis-associated sclerosing cholangitis. Pathol. Int. 55(7), 405-411 (2005).
71. Choi EK, Kim MH, Lee TY et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis- Korean experience. Pancreas 35(2), 158-163 (2007).
72. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 6(1-2), 132-137 (2006).
73. Hamano H, Kawa S, Horiuchi A et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344(10), 732-738 (2001).
74. Bossuyt X, Mariën G, Meyts I, Proesmans M, De Boeck K. Determination of IgG subclasses: a need for standardization. J. Allergy Clin. Immunol. 115(4), 872-874 (2005).
75. Stapel SO, Asero R, Ballmer-Weber BK et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI task force report. Allergy 63(7), 793-796 (2008).
76. Nouri-Aria KT, Wachholz PA, Francis JN et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J. Immunol. 172(5), 3252-3259 (2004).
77. Aalberse RC, Dieges PH, Knul-Bretlova V, Vooren P, Aalbers M, van Leeuwen J. IgG4 as a blocking antibody. In: Clinical Reviews in Allergy (Volume 1). Halpern GM (Ed.). Elsevier Biomedical, NY, USA, 289-302 (1983).
78. van der Neut KM, Schuurman J, Losen M et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317(5844), 1554-1557 (2007).
79. Matsushita M, Yamashina M, Ikeura T et al. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. Am. J. Gastroenterol. 102(1), 220-221 (2007).
80. Tanabe T, Tsushima K, Yasuo M et al. IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern. Med. 45(21), 1243-1247 (2006).
81. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J. Gastroenterol. 14(25), 3948-3955 (2008).
82. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J. Gastroenterol. 41(12), 1197-1205 (2006).
83. Shrestha B, Sekiguchi H, Colby TV et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am. J. Surg. Pathol. (2009) (Epub ahead of print).
84. Sitaru C, Zillikens D. Mechanisms of blister induction by autoantibodies. Exp. Dermatol. 14(12), 861-875 (2005).
85. Sitaru C, Mihai S, Zillikens D. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch. Dermatol. Res. 299(1), 1-8 (2007).
86. Rock B, Martins CR, Theofilopoulos AN et al. The pathogenic effect of IgG4 autoantibodies in endemic Pemphigus foliaceus (Fogo selvagem). N. Engl. J. Med. 320(22), 1463-1469 (1989).
87. Yeh SW, Cavacini LA, Bhol KC et al. Pathogenic human monoclonal antibody against desmoglein 3. Clin. Immunol. 120(1), 68-75 (2006).
88. Mihai S, Chiriac MT, Herrero-Gonzalez JE et al. IgG4 autoantibodies induce dermal-epidermal separation. J. Cell. Mol. Med. 11(5), 1117-1128 (2007).
89. Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 242(3), 791-801 (2007).
90. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J. Gastroenterol. 41(7), 613-625 (2006). (Pubitemid 44288524)
91. Zen Y, Fujii T, Harada K et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45(6), 1538-1546 (2007).
92. Saegusa H, Momose M, Kawa S et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas 27(1), 20-25 (2003).
93. Hirano K, Kawabe T, Komatsu Y et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern. Med. J. 36(1), 58-61 (2006).
94. Tsushima K, Tanabe T, Yamamoto H et al. Pulmonary involvement of autoimmune pancreatitis. Eur. J. Clin. Invest. 39(8), 714-722 (2009).
95. Deheragoda MG, Church NI, Rodriguez-Justo M et al. The use of immunoglobulin G4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin. Gastroenterol. Hepatol. 5(10), 1229-1234 (2007).
96. Church NI, Pereira SP, Deheragoda MG et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am. J. Gastroenterol. 102(11), 2417-2425 (2007).
97. Zandieh I, Byrne MF. Autoimmune pancreatitis: a review. World J. Gastroenterol. 13(47), 6327-6332 (2007).
98. Saeki T, Saito A, Yamazaki H et al. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin. Exp. Nephrol. 11(2), 168-173 (2007).
99. Deshpande V, Chicano S, Finkelberg D et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am. J. Surg. Pathol. 30(12), 1537-1545 (2006).
100. Cornell LD, Chicano SL, Deshpande V et al. Pseudotumors due to IgG4 immunecomplex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am. J. Surg. Pathol. 31(10), 1586-1597 (2007).
101. Okazaki K, Uchida K, Fukui T. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J. Gastroenterol. 43(6), 409-418 (2008).
102. Sepehr A, Lauwers GY. Gastrointestinal evidence of autoimmune pancreatitis: a rare manifestation. Histopathology 53(3), 358-359 (2008).
103. Tseng CW, Tsai JJ, Chen CC. Abdominal aortitis associated with autoimmune pancreatitis. Clin. Gastroenterol. Hepatol. 7(1), e3-e4 (2009).
104. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J. Gastroenterol. Hepatol. 24(1), 15-36 (2009).
105. Ghazale A, Chari ST, Smyrk TC et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am. J. Gastroenterol. 102(8), 1646-1653 (2007).
106. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand. J. Gastroenterol. 39(11), 1154-1158 (2004).
107. Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern. Med. 45(8), 497-501 (2006).
108. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 46(2), 463-471 (2007).
109. Pezzilli R, Casadei R, Santini D. Autoimmune pancreatitis associated with anisakis infection. Dig. Liver Dis. 39(3), 273 (2007).
110. Ohara H, Nakazawa T, Sano H et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 31(3), 232-237 (2005).